avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Ets1
|
ENSMUSG00000032035.9 | E26 avian leukemia oncogene 1, 5' domain |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Ets1 | mm10_v2_chr9_+_32696005_32696121 | 0.70 | 1.6e-06 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.2 | 27.6 | GO:0002148 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
5.1 | 20.2 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
3.9 | 11.7 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
3.7 | 11.0 | GO:0072382 | minus-end-directed vesicle transport along microtubule(GO:0072382) |
3.5 | 10.4 | GO:0070488 | neutrophil aggregation(GO:0070488) |
3.1 | 12.6 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
3.0 | 8.9 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) negative regulation of hypersensitivity(GO:0002884) |
2.6 | 15.4 | GO:0032439 | endosome localization(GO:0032439) negative regulation of vacuolar transport(GO:1903336) |
1.9 | 9.4 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.8 | 5.4 | GO:0030221 | basophil differentiation(GO:0030221) |
1.7 | 11.6 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
1.6 | 4.9 | GO:0071163 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) DNA replication preinitiation complex assembly(GO:0071163) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
1.6 | 8.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
1.6 | 1.6 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
1.5 | 4.5 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
1.4 | 4.2 | GO:0036292 | DNA rewinding(GO:0036292) |
1.3 | 4.0 | GO:0045763 | regulation of arginine metabolic process(GO:0000821) negative regulation of nitric oxide mediated signal transduction(GO:0010751) negative regulation of cellular amino acid metabolic process(GO:0045763) |
1.3 | 1.3 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
1.2 | 7.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.2 | 10.9 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
1.2 | 6.0 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
1.2 | 3.5 | GO:0071846 | actin filament debranching(GO:0071846) |
1.2 | 10.5 | GO:0036309 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
1.1 | 3.3 | GO:1904732 | regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
1.1 | 7.5 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
1.1 | 5.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.1 | 3.2 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
1.0 | 7.3 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
1.0 | 4.2 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
1.0 | 14.5 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.0 | 3.1 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
1.0 | 6.0 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
1.0 | 3.0 | GO:1904879 | pentose-phosphate shunt, oxidative branch(GO:0009051) positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
1.0 | 3.0 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
1.0 | 3.9 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
1.0 | 9.7 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.9 | 3.8 | GO:0015825 | L-serine transport(GO:0015825) |
0.9 | 7.5 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.9 | 1.8 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.9 | 11.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.9 | 7.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.9 | 8.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.9 | 12.4 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.9 | 2.6 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.9 | 2.6 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.8 | 13.3 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.8 | 3.2 | GO:0010286 | heat acclimation(GO:0010286) |
0.8 | 2.4 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.8 | 8.4 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.8 | 9.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.8 | 5.3 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.8 | 2.3 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.7 | 2.9 | GO:0030576 | Cajal body organization(GO:0030576) |
0.7 | 2.2 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
0.7 | 2.8 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
0.7 | 2.8 | GO:0045659 | negative regulation of neutrophil differentiation(GO:0045659) |
0.7 | 4.8 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.7 | 2.8 | GO:0046898 | response to cycloheximide(GO:0046898) |
0.7 | 2.0 | GO:1903972 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
0.7 | 2.0 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.7 | 4.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.7 | 3.3 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.7 | 9.3 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.7 | 2.0 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.7 | 0.7 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.6 | 2.6 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.6 | 3.2 | GO:0042117 | monocyte activation(GO:0042117) |
0.6 | 17.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.6 | 1.8 | GO:0032470 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) maintenance of mitochondrion location(GO:0051659) relaxation of skeletal muscle(GO:0090076) |
0.6 | 1.8 | GO:0010716 | regulation of collagen catabolic process(GO:0010710) negative regulation of extracellular matrix disassembly(GO:0010716) |
0.6 | 5.4 | GO:0002432 | granuloma formation(GO:0002432) |
0.6 | 4.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.6 | 5.9 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.6 | 5.9 | GO:0051014 | actin filament severing(GO:0051014) |
0.6 | 2.9 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.6 | 1.7 | GO:0032701 | negative regulation of granulocyte macrophage colony-stimulating factor production(GO:0032685) negative regulation of interleukin-18 production(GO:0032701) |
0.6 | 2.8 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.6 | 6.1 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.6 | 2.2 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.6 | 2.2 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.5 | 1.6 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.5 | 1.1 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.5 | 2.6 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.5 | 4.1 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.5 | 9.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.5 | 4.6 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.5 | 2.0 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.5 | 1.5 | GO:1904980 | regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
0.5 | 2.5 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.5 | 1.5 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.5 | 2.0 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.5 | 2.0 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.5 | 1.5 | GO:0035709 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.5 | 1.4 | GO:0002355 | detection of tumor cell(GO:0002355) |
0.5 | 5.2 | GO:0035878 | nail development(GO:0035878) |
0.5 | 6.1 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.5 | 7.9 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.5 | 2.3 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.5 | 1.8 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.5 | 2.8 | GO:0050916 | sensory perception of sweet taste(GO:0050916) sensory perception of umami taste(GO:0050917) |
0.5 | 2.3 | GO:0009597 | detection of virus(GO:0009597) |
0.5 | 1.8 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.4 | 8.9 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.4 | 1.3 | GO:0048611 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
0.4 | 7.9 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.4 | 0.4 | GO:0018307 | enzyme active site formation(GO:0018307) |
0.4 | 1.3 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.4 | 5.9 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.4 | 0.8 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.4 | 1.2 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.4 | 1.2 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.4 | 1.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.4 | 1.6 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.4 | 4.3 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.4 | 2.4 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.4 | 1.2 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.4 | 3.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.4 | 1.6 | GO:0061152 | negative regulation of interleukin-13 production(GO:0032696) trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) odontoblast differentiation(GO:0071895) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.4 | 1.2 | GO:1901355 | response to rapamycin(GO:1901355) |
0.4 | 4.2 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.4 | 5.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.4 | 3.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.4 | 1.1 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
0.4 | 0.7 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.4 | 2.6 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.4 | 4.8 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.4 | 2.2 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.4 | 2.8 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.4 | 2.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.4 | 1.8 | GO:0044849 | estrous cycle(GO:0044849) |
0.3 | 3.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.3 | 0.7 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.3 | 0.7 | GO:2000043 | regulation of cardiac cell fate specification(GO:2000043) |
0.3 | 8.3 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.3 | 0.7 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.3 | 6.2 | GO:0050913 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) sensory perception of bitter taste(GO:0050913) |
0.3 | 13.6 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.3 | 4.2 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.3 | 5.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.3 | 1.6 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.3 | 5.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.3 | 1.6 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.3 | 1.2 | GO:1903027 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.3 | 0.9 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.3 | 1.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 0.9 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
0.3 | 1.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.3 | 0.9 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.3 | 0.9 | GO:0048478 | replication fork protection(GO:0048478) |
0.3 | 4.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.3 | 0.9 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.3 | 0.9 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.3 | 4.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.3 | 0.6 | GO:0072708 | response to sorbitol(GO:0072708) |
0.3 | 0.9 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.3 | 0.6 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.3 | 1.4 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.3 | 1.1 | GO:1904796 | regulation of core promoter binding(GO:1904796) |
0.3 | 15.5 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.3 | 1.4 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.3 | 0.8 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
0.3 | 3.8 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.3 | 1.1 | GO:0031296 | B cell costimulation(GO:0031296) |
0.3 | 4.8 | GO:0001675 | acrosome assembly(GO:0001675) |
0.3 | 0.8 | GO:0070476 | rRNA (guanine-N7)-methylation(GO:0070476) |
0.3 | 0.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 0.5 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.3 | 0.8 | GO:0032962 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.3 | 3.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.3 | 0.5 | GO:2000554 | T-helper 1 cell cytokine production(GO:0035744) regulation of T-helper 1 cell cytokine production(GO:2000554) positive regulation of T-helper 1 cell cytokine production(GO:2000556) |
0.3 | 1.0 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.3 | 1.3 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.3 | 1.5 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.3 | 5.1 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.3 | 2.5 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.3 | 1.0 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.2 | 1.7 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 1.5 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.2 | 1.0 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.2 | 0.7 | GO:1903660 | transforming growth factor beta activation(GO:0036363) regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.2 | 2.4 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.2 | 6.5 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.2 | 0.9 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 1.4 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.2 | 1.4 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.2 | 1.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 1.4 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.2 | 1.1 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.2 | 3.4 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.2 | 0.9 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.2 | 9.2 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.2 | 0.4 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.2 | 2.9 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.2 | 0.7 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.2 | 1.3 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.2 | 1.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 1.1 | GO:0001840 | neural plate development(GO:0001840) |
0.2 | 0.9 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.2 | 0.9 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 0.4 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.2 | 1.7 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.2 | 2.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 0.4 | GO:0021506 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
0.2 | 1.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 7.5 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.2 | 1.0 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.2 | 1.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 1.6 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 1.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 2.2 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.2 | 0.6 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.2 | 2.0 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.2 | 1.3 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 2.7 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.2 | 1.2 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.2 | 1.1 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 1.0 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.2 | 3.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 2.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 2.4 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.2 | 1.9 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.2 | 3.9 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.2 | 0.7 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) cellular response to sodium arsenite(GO:1903936) |
0.2 | 1.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.2 | 5.7 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.2 | 1.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.2 | 0.2 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.2 | 1.1 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.2 | 7.0 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.2 | 0.9 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 1.4 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.2 | 0.2 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.2 | 0.5 | GO:0002587 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) negative regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002587) |
0.2 | 0.7 | GO:0061146 | midgut development(GO:0007494) Peyer's patch morphogenesis(GO:0061146) |
0.2 | 0.5 | GO:0002305 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.2 | 7.9 | GO:0006284 | base-excision repair(GO:0006284) |
0.2 | 2.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 5.5 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.2 | 1.4 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.2 | 1.0 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.2 | 1.3 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.2 | 4.9 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.2 | 0.8 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.2 | 1.8 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.2 | 0.6 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 1.1 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.2 | 0.8 | GO:1902167 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902167) |
0.2 | 3.0 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 3.3 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.2 | 1.4 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 3.4 | GO:0099612 | protein localization to axon(GO:0099612) |
0.2 | 0.8 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.2 | 6.5 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.2 | 1.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 2.0 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 7.8 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 2.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.6 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.1 | 1.0 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.4 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 1.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.7 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 2.6 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.9 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.1 | 3.3 | GO:0045954 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.9 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 1.7 | GO:0098792 | xenophagy(GO:0098792) |
0.1 | 0.3 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 1.0 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.4 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 0.3 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.1 | 2.2 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.6 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 4.0 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.1 | 1.4 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.1 | 0.9 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.5 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.3 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.4 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.1 | 1.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.4 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.1 | 3.1 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 0.5 | GO:0021764 | amygdala development(GO:0021764) |
0.1 | 0.8 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.1 | 1.0 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.4 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.1 | 0.9 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.2 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.1 | 0.4 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
0.1 | 0.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.5 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.5 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.1 | 0.5 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.1 | 2.8 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.9 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.5 | GO:0032218 | riboflavin transport(GO:0032218) |
0.1 | 0.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.4 | GO:0031509 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
0.1 | 0.1 | GO:0032202 | negative regulation of protein ADP-ribosylation(GO:0010836) telomere assembly(GO:0032202) |
0.1 | 2.4 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.4 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 3.3 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 1.2 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.1 | 4.4 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 1.8 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.1 | 0.5 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.1 | 0.2 | GO:0002339 | B cell selection(GO:0002339) B cell negative selection(GO:0002352) |
0.1 | 2.3 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 0.5 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.1 | 0.1 | GO:0061010 | gall bladder development(GO:0061010) |
0.1 | 3.3 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 1.4 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.5 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.1 | 4.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 1.9 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 1.2 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 8.6 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
0.1 | 0.5 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 4.1 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 3.1 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.1 | 2.2 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.1 | 0.7 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 6.5 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.1 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 1.1 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.7 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.7 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.8 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.1 | 0.3 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 1.1 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 2.5 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.5 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 2.6 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
0.1 | 0.9 | GO:1904871 | protein localization to nuclear body(GO:1903405) positive regulation of establishment of protein localization to telomere(GO:1904851) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.1 | 1.4 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.4 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.1 | 2.7 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.1 | 0.4 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 2.9 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.1 | 2.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.3 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.5 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
0.1 | 3.5 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 1.2 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.1 | 0.1 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
0.1 | 2.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 2.5 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 1.3 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
0.1 | 0.3 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.1 | 0.3 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.1 | 1.3 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 1.9 | GO:0060004 | reflex(GO:0060004) |
0.1 | 0.8 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.7 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 1.5 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 0.2 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.1 | 0.5 | GO:1900120 | regulation of receptor binding(GO:1900120) |
0.1 | 2.1 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.1 | 0.2 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 0.5 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 0.4 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.8 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.1 | 0.1 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.1 | 1.1 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 0.3 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.1 | 1.8 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.2 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.1 | 0.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.1 | 0.4 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) positive regulation of glycogen metabolic process(GO:0070875) |
0.1 | 0.7 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 1.8 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 0.1 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.0 | 0.7 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 1.1 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.0 | 0.4 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.0 | 1.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.4 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.4 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.0 | 0.4 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.0 | 0.4 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 1.2 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.8 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.0 | 0.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.2 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.0 | 0.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 1.8 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 1.1 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.3 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.0 | 0.6 | GO:0035196 | production of miRNAs involved in gene silencing by miRNA(GO:0035196) |
0.0 | 3.4 | GO:0007338 | single fertilization(GO:0007338) |
0.0 | 0.3 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.0 | 0.9 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.3 | GO:0071362 | interleukin-21 production(GO:0032625) cellular response to ether(GO:0071362) interleukin-21 secretion(GO:0072619) response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.0 | 0.3 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.7 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.1 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.0 | 1.3 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.0 | GO:0046619 | optic placode formation(GO:0001743) optic placode formation involved in camera-type eye formation(GO:0046619) |
0.0 | 0.6 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.8 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.0 | 2.0 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.4 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.0 | 0.7 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.0 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
0.0 | 2.0 | GO:0001889 | liver development(GO:0001889) |
0.0 | 0.4 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.0 | 0.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.0 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 1.0 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.0 | 0.6 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) |
0.0 | 1.2 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.9 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.6 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 1.1 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.6 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.2 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.0 | 0.1 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.0 | 0.6 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.1 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.0 | 0.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 1.0 | GO:0043473 | pigmentation(GO:0043473) |
0.0 | 0.6 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.0 | 1.8 | GO:0000398 | RNA splicing, via transesterification reactions(GO:0000375) RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.0 | 0.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 13.7 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
2.7 | 16.2 | GO:0097443 | sorting endosome(GO:0097443) |
2.5 | 7.5 | GO:0000799 | nuclear condensin complex(GO:0000799) |
2.0 | 6.1 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
1.6 | 4.9 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
1.6 | 24.8 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.5 | 17.9 | GO:0072687 | meiotic spindle(GO:0072687) |
1.3 | 9.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.2 | 6.2 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
1.2 | 15.9 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.2 | 8.2 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
1.1 | 13.0 | GO:0005687 | U4 snRNP(GO:0005687) |
1.1 | 5.3 | GO:1990769 | proximal neuron projection(GO:1990769) |
1.0 | 8.3 | GO:0005818 | aster(GO:0005818) |
0.9 | 3.6 | GO:0008623 | CHRAC(GO:0008623) |
0.9 | 9.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.9 | 5.2 | GO:1990393 | 3M complex(GO:1990393) |
0.8 | 9.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.8 | 2.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.8 | 10.7 | GO:0042555 | MCM complex(GO:0042555) |
0.8 | 2.3 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.7 | 2.2 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.7 | 2.9 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
0.7 | 4.7 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.7 | 2.0 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.6 | 5.8 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.6 | 4.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.6 | 3.7 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.6 | 3.0 | GO:0042583 | chromaffin granule(GO:0042583) |
0.6 | 7.0 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.6 | 10.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.5 | 4.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.5 | 1.6 | GO:0036019 | endolysosome(GO:0036019) |
0.5 | 3.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.5 | 2.0 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.5 | 1.0 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.5 | 23.5 | GO:0031430 | M band(GO:0031430) |
0.5 | 2.9 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.5 | 6.5 | GO:0031527 | filopodium membrane(GO:0031527) |
0.5 | 5.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.5 | 1.8 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.4 | 22.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.4 | 3.7 | GO:0008278 | cohesin complex(GO:0008278) |
0.4 | 11.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 1.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.4 | 3.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 1.2 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.4 | 1.5 | GO:1902737 | viral replication complex(GO:0019034) dendritic filopodium(GO:1902737) |
0.4 | 5.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.4 | 2.9 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 19.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.3 | 10.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.3 | 1.9 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.3 | 1.8 | GO:0031673 | H zone(GO:0031673) |
0.3 | 1.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.3 | 0.9 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.3 | 5.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.3 | 1.7 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.3 | 22.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.3 | 0.8 | GO:0071007 | U2-type catalytic step 2 spliceosome(GO:0071007) |
0.3 | 1.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.3 | 1.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 2.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 1.0 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.3 | 13.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 2.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.2 | 1.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 1.9 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 3.6 | GO:0031672 | A band(GO:0031672) |
0.2 | 1.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 3.1 | GO:0000974 | Prp19 complex(GO:0000974) |
0.2 | 2.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 11.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 0.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 3.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.2 | 3.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 12.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 1.1 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 8.7 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 24.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 0.4 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.2 | 1.4 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 0.4 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 5.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 1.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 3.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.2 | 0.8 | GO:0005688 | U6 snRNP(GO:0005688) |
0.2 | 1.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 7.0 | GO:0002102 | podosome(GO:0002102) |
0.2 | 0.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 0.9 | GO:1990745 | EARP complex(GO:1990745) |
0.2 | 12.9 | GO:0030118 | clathrin coat(GO:0030118) |
0.2 | 1.6 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.2 | 2.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 1.4 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 0.6 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.7 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.1 | 2.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 4.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 1.4 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 2.5 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 1.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 1.6 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 7.4 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 1.9 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.4 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 3.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 1.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 4.1 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 3.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 2.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.5 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.1 | 3.5 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 1.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 9.3 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 0.9 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 1.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 1.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 1.6 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.1 | 1.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.3 | GO:0005940 | septin ring(GO:0005940) |
0.1 | 0.7 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 1.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 1.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 1.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 1.8 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 1.2 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.7 | GO:0005767 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
0.1 | 1.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 1.6 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.8 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 5.0 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.5 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 1.1 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.4 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 1.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.5 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 6.5 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.7 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 2.8 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 25.2 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.2 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.3 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 4.0 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 4.6 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 1.5 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 1.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 1.1 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.5 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 3.4 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.4 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 1.4 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 0.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 4.8 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.9 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 5.5 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 4.6 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 0.4 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.0 | 0.1 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.7 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 1.8 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.9 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 1.0 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.5 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 1.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.1 | GO:0070187 | telosome(GO:0070187) |
0.0 | 2.4 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.9 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 4.0 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.3 | GO:0044452 | nucleolar part(GO:0044452) |
0.0 | 3.4 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 1.3 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.0 | 1.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.1 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 0.7 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 1.7 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.6 | GO:0034707 | chloride channel complex(GO:0034707) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 10.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.9 | 7.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.7 | 8.6 | GO:0042610 | CD8 receptor binding(GO:0042610) |
1.6 | 13.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
1.6 | 7.9 | GO:0030621 | U4 snRNA binding(GO:0030621) |
1.5 | 13.2 | GO:0033691 | sialic acid binding(GO:0033691) |
1.4 | 4.3 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
1.4 | 5.5 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
1.2 | 11.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.2 | 19.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.2 | 12.7 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
1.1 | 4.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.1 | 1.1 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
1.0 | 2.9 | GO:0070140 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
0.9 | 3.7 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.9 | 2.6 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.9 | 6.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.8 | 8.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.8 | 2.5 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.8 | 4.7 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.8 | 2.3 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.8 | 4.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.8 | 6.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.7 | 3.0 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.7 | 3.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.7 | 2.2 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.7 | 2.9 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.7 | 5.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.7 | 2.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.7 | 2.8 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.7 | 4.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.7 | 7.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.7 | 3.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.7 | 2.0 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.6 | 2.5 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.6 | 12.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.6 | 3.7 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.6 | 3.0 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.6 | 1.2 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.6 | 5.8 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.6 | 10.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.5 | 9.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.5 | 1.6 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
0.5 | 1.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.5 | 1.6 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.5 | 4.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.5 | 1.6 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
0.5 | 6.7 | GO:0005522 | profilin binding(GO:0005522) |
0.5 | 5.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.5 | 1.5 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.5 | 16.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.5 | 4.9 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.5 | 1.5 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.5 | 1.9 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.5 | 1.4 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.5 | 1.9 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.5 | 2.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.5 | 6.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.5 | 2.8 | GO:0051425 | PTB domain binding(GO:0051425) |
0.4 | 4.0 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.4 | 1.8 | GO:0000010 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.4 | 2.9 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.4 | 2.9 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.4 | 3.3 | GO:0004064 | arylesterase activity(GO:0004064) |
0.4 | 4.1 | GO:0008527 | taste receptor activity(GO:0008527) |
0.4 | 9.7 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.4 | 2.0 | GO:0043532 | angiostatin binding(GO:0043532) |
0.4 | 3.3 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.4 | 0.7 | GO:0002135 | CTP binding(GO:0002135) |
0.4 | 2.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.4 | 6.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.4 | 1.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.3 | 9.8 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.3 | 10.0 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.3 | 1.4 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
0.3 | 0.7 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.3 | 4.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 1.0 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.3 | 3.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.3 | 6.5 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 1.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 2.6 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.3 | 4.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 1.2 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.3 | 1.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 1.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 1.5 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.3 | 4.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.3 | 56.7 | GO:0008201 | heparin binding(GO:0008201) |
0.3 | 6.9 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.3 | 1.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 5.8 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.3 | 0.8 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.3 | 2.7 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.3 | 1.9 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.3 | 5.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.3 | 1.3 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.3 | 12.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 0.8 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.3 | 1.5 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.2 | 2.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 2.0 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 0.7 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.2 | 1.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 8.6 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.2 | 2.5 | GO:0031014 | troponin T binding(GO:0031014) |
0.2 | 4.4 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.2 | 1.5 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.2 | 5.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.2 | 0.7 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.2 | 3.8 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.2 | 0.9 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 0.9 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 9.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 1.5 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.2 | 2.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 5.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 1.8 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 2.9 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 7.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 1.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 9.8 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.2 | 5.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 0.8 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.2 | 31.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 0.8 | GO:0070976 | calcium-independent protein kinase C activity(GO:0004699) TIR domain binding(GO:0070976) |
0.2 | 1.9 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 4.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 2.8 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.2 | 2.9 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 0.5 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.2 | 1.4 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) |
0.2 | 0.5 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.2 | 1.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.2 | 1.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 9.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 2.8 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.2 | 2.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 5.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 2.0 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 0.8 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.2 | 1.8 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 11.5 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 3.2 | GO:0032183 | SUMO binding(GO:0032183) |
0.2 | 1.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 1.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 1.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 1.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 2.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 1.4 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 1.5 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 1.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 1.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 1.9 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.5 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.4 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.1 | 0.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.4 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 5.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 2.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.9 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.8 | GO:1903136 | copper chaperone activity(GO:0016531) cuprous ion binding(GO:1903136) |
0.1 | 1.0 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 8.4 | GO:0008026 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) ATP-dependent helicase activity(GO:0008026) RNA-dependent ATPase activity(GO:0008186) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 0.8 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.2 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 0.5 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 2.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.5 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.1 | 1.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 0.4 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 1.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 0.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.6 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.4 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.1 | 3.3 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 1.3 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.1 | 1.4 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.3 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.1 | 0.8 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 4.9 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.3 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.1 | 2.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 3.8 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 4.1 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 3.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.1 | GO:0070990 | snRNP binding(GO:0070990) |
0.1 | 2.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 3.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 28.4 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 3.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.4 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 8.1 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 0.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 2.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 10.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 1.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.8 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.1 | 2.5 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 1.0 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 1.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 8.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.2 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.1 | 0.7 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 2.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 1.9 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.1 | 0.2 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 0.4 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 2.6 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.1 | 1.1 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 1.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.8 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 1.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.4 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 1.0 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.4 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 2.9 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 1.9 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.1 | GO:0030984 | kininogen binding(GO:0030984) |
0.0 | 0.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 1.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 2.6 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 0.2 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.5 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 1.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 2.8 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.1 | GO:0001031 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) 5S rDNA binding(GO:0080084) |
0.0 | 0.4 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.0 | 2.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 1.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) chromo shadow domain binding(GO:0070087) |
0.0 | 0.4 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 1.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.7 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.2 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.0 | 0.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.1 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.1 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.0 | 2.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 2.1 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.6 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 1.0 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.9 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.2 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.9 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.0 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
0.0 | 0.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.0 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 1.2 | GO:0042393 | histone binding(GO:0042393) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 29.8 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.7 | 10.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.6 | 30.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.6 | 9.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.6 | 23.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.5 | 23.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.5 | 32.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.4 | 19.2 | PID ATR PATHWAY | ATR signaling pathway |
0.4 | 12.0 | PID AURORA A PATHWAY | Aurora A signaling |
0.3 | 5.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 2.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 2.5 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 6.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 11.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 5.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 5.8 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.3 | 10.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 26.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 7.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 2.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 4.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 11.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 5.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 5.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 7.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 0.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 2.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 4.9 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 7.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 0.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 2.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 6.0 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 3.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 3.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 6.7 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 1.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 3.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 11.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 4.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 5.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 2.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 1.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 1.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 2.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 3.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 19.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 1.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.3 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 2.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 1.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 17.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 4.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 1.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 2.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 2.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 1.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 1.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.4 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 1.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.1 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.9 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 4.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.9 | 13.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.8 | 6.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.8 | 7.0 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.7 | 13.0 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.6 | 11.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.6 | 6.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.6 | 32.6 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.6 | 7.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.6 | 10.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.6 | 6.7 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.6 | 1.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.5 | 3.1 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.4 | 5.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.4 | 9.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.4 | 5.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.4 | 19.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.4 | 2.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.4 | 5.8 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.4 | 13.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.4 | 1.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 5.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.3 | 8.9 | REACTOME KINESINS | Genes involved in Kinesins |
0.3 | 4.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 7.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.3 | 8.0 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 33.7 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.3 | 7.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 1.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.3 | 2.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.3 | 5.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 8.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.3 | 3.0 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.3 | 1.6 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 3.7 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 5.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 4.9 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 9.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 2.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 8.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 1.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 6.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 1.1 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.2 | 5.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 4.7 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.2 | 33.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 6.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 1.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 1.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.2 | 6.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 5.9 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 2.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 1.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 5.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 5.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 2.7 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 4.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 1.0 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 4.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 2.8 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 0.8 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 0.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 5.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 5.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 1.4 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 1.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 1.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 3.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 0.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 1.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.5 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.9 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 1.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.4 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 1.0 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 2.5 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.3 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.6 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.0 | 0.8 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 1.1 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 1.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 3.7 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.6 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.0 | 0.8 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.0 | 0.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.1 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.3 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.0 | 0.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.6 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |